MacroGenics, Inc. (MGNX)
3.52
+0.11
(+3.23%)
USD |
NASDAQ |
Apr 17, 12:34
MacroGenics Free Cash Flow : -82.95M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Amgen, Inc. | 8.10B |
| Amicus Therapeutics, Inc. | 29.85M |
| Merck & Co., Inc. | 12.36B |
| Pfizer Inc. | 9.076B |
| Xencor, Inc. | -138.27M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 43.02M |
| Cash from Investing (Quarterly) | -65.99M |
| Cash from Financing (Quarterly) | 0.057M |
| Free Cash Flow Per Share (Quarterly) | 0.6756 |
| Free Cash Flow to Equity (Quarterly) | 43.28M |
| Free Cash Flow to Firm (Quarterly) | 46.83M |
| Free Cash Flow Yield | -37.30% |